Back to search

Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB

Data up to Jan 2025

Published2005
Citations2,161
References50
Clinical Trials (1)

Total Citations Per Year

Abstract

References (50)

Obesity is associated with macrophage accumulation in adipose tissue

2003 • 8,349 citations

Obesity is associated with macrophage accumulation in adipose tissue

2003 • 7,795 citations

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1993 • 7,219 citations

Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001

2003 • 5,872 citations

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

2003 • 5,744 citations

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

2003 • 5,391 citations

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

2001 • 4,289 citations

Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents

2013 • 2,971 citations

Suppression of TNF-α-Induced Apoptosis by NF-κB

1996 • 2,623 citations

Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

2001 • 1,849 citations

Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes

2003 • 1,435 citations

IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice

2004 • 1,267 citations

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction

2002 • 1,264 citations

Fat Accumulation in the Liver Is Associated with Defects in Insulin Suppression of Glucose Production and Serum Free Fatty Acids Independent of Obesity in Normal Men

2002 • 1,057 citations

Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes

2002 • 1,053 citations

Is Type II diabetes mellitus a disease of the innate immune system?

1998 • 1,040 citations

Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects

2003 • 1,014 citations

Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation

1999 • 855 citations

Introns increase transcriptional efficiency in transgenic mice.

1988 • 733 citations

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

2004 • 729 citations

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

2003 • 716 citations

Inflammatory pathways and insulin action

2003 • 716 citations

Prevention of fat-induced insulin resistance by salicylate

2001 • 713 citations

Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

2000 • 692 citations

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

2002 • 614 citations

Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

1993 • 543 citations

NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176

1998 • 533 citations

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

2002 • 529 citations

Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo

2004 • 526 citations

Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice

2003 • 477 citations

Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance

2003 • 447 citations

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.

2000 • 435 citations

Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance

2003 • 425 citations

Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical Samples

1992 • 384 citations

Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone

2003 • 360 citations

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

2003 • 359 citations

Phosphorylation of IκBα Precedes but Is Not Sufficient for Its Dissociation from NF-κB

1995 • 351 citations

Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice.

1990 • 343 citations

Troglitazone action is independent of adipose tissue.

1997 • 340 citations

IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex

1999 • 333 citations

Insulin Sensitivity and Its Measurement: Structural Commonalities among the Methods1

2000 • 293 citations

Interleukin 1? and interleukin 6, but not tumor necrosis factor ?, inhibit insulin-stimulated glycogen synthesis in rat hepatocytes

1998 • 135 citations

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial

2001 • 133 citations

Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance

2004 • 97 citations

Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance

2004 • 78 citations

[25] Signaling pathways leading to nuclear factor-κB activation

2000 • 49 citations

JMM - Past and Present

2002 • 30 citations

Invited comment on W. Ebstein: On the therapy of diabetes mellitus, in particular on the application of sodium salicylate.

2002 • 29 citations

Inflammation and Its Relationship to Insulin Resistance, Type 2 Diabetes Mellitus, and Endothelial Dysfunction

2003 • 25 citations

Invited comment on W. Ebstein: On the therapy of diabetes mellitus, in particular on the application of sodium salicylate

2002 • 15 citations

Cited By (0)

No citing papers found in database

Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB (2005) – Nature Medicine | Metascience Observatory Explorer